Name:
Mefenorex
Type:
Stimulant
AKA:
Anorexic, Amexate, Doracil, Pondinil
Mefenorex image
Synthetic substance, no natural derivative
IUPAC Logo
Mefenorex image
Mefenorex, a stimulant, was first developed in the 1960s. It was introduced for its anorectic effects and was used in the treatment of obesity. The compound's use has been limited due to safety concerns and regulatory controls.
Synthetic Substances Image
Mefenorex is a stimulant with appetite-suppressing properties. It acts as an upper, increasing energy and reducing appetite. Short-term use may aid in weight loss, but long-term use poses risks of cardiovascular issues and potential dependency. Overdose risks include severe agitation and cardiovascular effects. Safe use requires cautious dosing. Recent research explores its stimulant effects and potential health risks.
N/A
Mefenorex, a stimulant, affects norepinephrine and dopamine systems, leading to increased alertness and euphoria. Immediate effects include heightened mood and cognition, with long-term use potentially causing dependence and psychological issues. Research focuses on its stimulant properties and abuse potential.
N/A
Mefenorex is a stimulant drug with no historical lore but gained prominence in the late 20th century for weight loss. Its use is primarily recreational and medicinal, reflecting broader themes in appetite control and weight management. Proponents highlight its effectiveness, while opponents warn of potential side effects and misuse. Its cultural significance is tied to debates about obesity treatment and stimulant regulation.
N/A